| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65682d3e437c225d79b93953b4b26392 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2086 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| filingDate |
2021-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ee1c66396b8a7b9f53825c16ff22d7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cdeea28e03fd4d3e32e54a0bf115b4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc5a3457e56b4ea4f474b47bb9b3c625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16591ac161603bcd18a8d373eaa2c254 |
| publicationDate |
2021-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113476461-A |
| titleOfInvention |
A kind of drug for improving the chemotaxis of anti-inflammatory macrophages and its application |
| abstract |
The invention discloses a drug for improving the chemotaxis of anti-inflammatory macrophages and its application, in particular to the application of glucosamine in the preparation of a drug for improving the chemotaxis of anti-inflammatory macrophages. Does not affect the pro-inflammatory or anti-inflammatory polarization of macrophages, but significantly increases the chemotaxis of anti-inflammatory macrophages to CX3CL1. |
| priorityDate |
2021-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |